Skip to main content
Symptom
dx.
Menu
Clinical Reference
Approaches
I have a symptom
Management
I know the diagnosis
Orthopedic Injuries
Fractures & dislocations
Calculators
Clinical calculators
Practical Skills
ECG
Interpretation guide
POCUS
Bedside ultrasound
Procedures
Step-by-step guides
Resuscitation
ACLS / PALS / NRP
Learn
Blog
Articles & updates
Deep Dive
In-depth clinical reviews
About
Our mission
Symptom
dx.
Clinical Reference
Approaches
I have a symptom
Management
I know the diagnosis
Orthopedic Injuries
Fractures & dislocations
Calculators
Clinical calculators
Practical Skills
ECG
Interpretation guide
POCUS
Bedside ultrasound
Procedures
Step-by-step guides
Resuscitation
ACLS / PALS / NRP
Learn
Blog
Articles & updates
Deep Dive
In-depth clinical reviews
About
Our mission
Get Started
Menu
Clinical Reference
Approaches
I have a symptom
Management
I know the diagnosis
Orthopedic Injuries
Fractures & dislocations
Calculators
Clinical calculators
Practical Skills
ECG
Interpretation guide
POCUS
Bedside ultrasound
Procedures
Step-by-step guides
Resuscitation
ACLS / PALS / NRP
Learn
Blog
Articles & updates
Deep Dive
In-depth clinical reviews
About
Our mission
Loading...
Anthrax (Gastrointestinal)
Cardiovascular Presentations
Abdominal aortic aneurysm
Acute coronary syndrome (NSTEMI)
Acute coronary syndrome (STEMI)
Acute decompensated heart failure
Acute limb ischemia
Acute mesenteric ischemia
Aortic dissection
Aortic stenosis
Atrial fibrillation and flutter
Bradyarrhythmia and heart block
Cardiac arrest
Deep vein thrombosis
Myocarditis
Pericarditis
Pulmonary embolism
Stable angina
Superficial thrombophlebitis
Superior vena cava syndrome
Supraventricular tachycardia
Syncope (cardiogenic)
Unstable angina
Ventricular tachycardia
Respiratory Presentations
Acute bronchitis
Acute respiratory failure
Aspiration pneumonia
Asthma exacerbation
Bronchiolitis
Community-acquired pneumonia
COVID-19 pneumonia
COPD exacerbation
Croup
Croup (laryngotracheobronchitis)
Epiglottitis
Hemothorax
Hospital-acquired pneumonia
Pleural effusion
Pneumothorax (traumatic)
Pulmonary contusion
Spontaneous pneumothorax
Neurological Presentations
Bell's palsy
Benign paroxysmal positional vertigo
Brain abscess
Cauda equina syndrome
Cervical radiculopathy
Concussion (mild traumatic brain injury)
Encephalitis
Guillain-Barré syndrome
Hemorrhagic stroke (intracerebral)
Ischemic stroke
Lumbar radiculopathy
Malignant spinal cord compression
Migraine
Peripheral neuropathy (acute)
Retropharyngeal abscess
Schizophrenia (acute exacerbation)
Seizure (breakthrough:known epilepsy)
Seizure (first-time)
Spinal cord injury
Status epilepticus
Subarachnoid hemorrhage
Tension headache
Transient ischemic attack
Traumatic brain injury (moderate-severe)
Vestibular neuritis
Viral meningitis
Gastrointestinal Presentations
Acute appendicitis
Acute cholecystitis
Acute diverticulitis
Acute pancreatitis
Anal fissure
Choledocholithiasis and cholangitis
Clostridioides difficile colitis
Gastritis
Gastroenteritis (viral and bacterial)
Gastroesophageal reflux disease
Incarcerated or strangulated hernia
Inflammatory bowel disease flare
Large bowel obstruction
Lower GI hemorrhage
Peptic ulcer disease
Perforated viscus
Small bowel obstruction
Upper GI hemorrhage
Genitourinary and Reproductive Presentations
Acute prostatitis
Acute urinary retention
Ectopic pregnancy
Epididymitis
Orchitis
Ovarian torsion
Paraphimosis
Pelvic inflammatory disease
Priapism
Pyelonephritis
Renal laceration
Ruptured ovarian cyst
Testicular torsion
Tubo-ovarian abscess
Urinary tract infection (uncomplicated)
Urolithiasis (renal colic)
Vaginal bleeding (non-pregnant)
Infectious Disease Presentations
Acute sinusitis
Acute tonsillitis
Acute upper respiratory infection
Animal bite
Bacterial meningitis
Cellulitis
Conjunctivitis (bacterial)
Dental abscess
Endocarditis
Febrile neutropenia
Fournier gangrene
Hand-foot-mouth disease
Hepatitis (acute)
Herpes zoster
HIV-related illness
Human bite
Impetigo
Infected diabetic foot ulcer
Infectious mononucleosis
Influenza
Necrotizing fasciitis
Osteomyelitis
Otitis externa
Parasitic infection
Periorbital cellulitis
Peritonsillar abscess
Scabies
Sepsis
Septic arthritis
Spontaneous bacterial peritonitis
Tick-borne illness (Lyme disease)
Tinea infection
Tuberculosis
Viral exanthem
Wound infection
Trauma Presentations
Achilles tendon rupture
ACL and mceniscus tear
Ankle fracture
Ankle sprain
Burn
Calcaneus fracture
Cervical spine fracture
Clavicle fracture
Dental avulsion
Distal radius fracture
Drowning
Elbow fracture and dislocation
Electrical injury
Facial bone fracture
Facial laceration
Femur fracture
Fingertip amputation
Forearm fracture (radius and ulna)
Frostbite
Hand:finger laceration
Heat exhaustion
Heat stroke
Hip fracture
Humeral shaft fracture
Knee dislocation
Knee sprain
Lightning injury
Mandible fracture
Metacarpal fracture
Metatarsal fracture
Muscle strain
Nasal fracture
Non-accidental trauma
Orbital fracture
Patella fracture
Phalanx fracture (finger)
Proximal humerus fracture
Pulmonary contusion
Rib fracture
Rotator cuff tear (acute traumatic)
Scalp laceration
Scaphoid fracture
Shoulder dislocation
Skull fracture
Splenic laceration
Sternal fracture
Supracondylar pediatric fracture
Tendon laceration (hand:wrist)
Thoracic and lumbar spine fracture
Tibia:fibula fracture
Tibial plateau fracture
Toe fracture
Traumatic epistaxis
Traumatic hyphema
Toxicologic Presentations
Acetaminophen toxicity
Alcohol intoxication
Alcohol withdrawal
Anticholinergic toxicity
Anticoagulant overdose
Benzodiazepine overdose
Benzodiazepine:sedative overdose
Beta-blocker and calcium channel blocker toxicity
Carbon monoxide poisoning
Caustic ingestion
Digoxin toxicity
Drug eruption
Foreign body ingestion
Opioid intoxication
Opioid overdose
Opioid withdrawal
Organophosphate
Salicylate toxicity
Serotonin syndrome
Stimulant intoxication (cocaine, methamphetamine)
Tricyclic antidepressant overdose
Psychiatric Presentations
Acute anxiety
Acute psychosis
Agitation:behavioral emergency
Bipolar disorder
Conversion disorder
Major depressive episode
Neuroleptic malignant syndrome
Suicidal ideation and attempt
Musculoskeletal and Rheumatologic Presentations
Acute low back pain (mechanical)
Bursitis
Cervical radiculopathy
Costochondritis
Gout (acute)
Lumbar radiculopathy
Pseudogout
Tendinitis
Dermatology Presentations
Acute eczema (Eczema acute flare)
Allergic contact dermatitis
Erythema multiforme
Henoch-Schönlein purpura
Pressure injury
Psoriasis (acute flare)
Stevens-Johnson syndrome
Toxic epidermal necrolysis
Urticaria (acute)
Environmental and Exposure Presentations
Envenomation (snake, spider, insect)
High-altitude illness
Hypothermia
Hematologic and Oncologic Presentations
Acute chest syndrome
Coagulopathy
Hyperviscosity syndrome
Sickle cell crisis (vaso-occlusive)
Symptomatic anemia
Thrombocytopenia (severe)
Tumor lysis syndrome
Pediatric-Specific Presentations
Bronchiolitis
Croup
Emergency delivery
Febrile seizure
Kawasaki disease
Neonatal jaundice
Neonatal sepsis
Nursemaid's elbow
Pediatric fever 0 to 28 days
Pediatric fever 29 to 60 days
Pediatric fever 61 to 90 days
Pyloric stenosis
Slipped capital femoral epiphysis
Intussusception
Endocrine and Metabolic Presentations
Adrenal crisis
Diabetic ketoacidosis
Hypercalcemia
Hyperosmolar hyperglycemic state
Hypertensive emergency
Hypertensive urgency
Hypoglycemia
Myasthenia gravis crisis
Myxedema coma
Severe hyperkalemia
Severe hyponatremia
Thyroid storm
ENT and Maxillofacial Presentations
Acute laryngitis
Acute otitis media
Acute pharyngitis
Cerumen impaction
Epistaxis (anterior)
Nasal foreign body
Otitis externa
Tympanic membrane perforation
Ophthalmologic Presentations
Acute angle-closure glaucoma
Central retinal artery occlusion
Chemical eye injury
Corneal abrasion
Corneal ulcer
Globe rupture
Ocular foreign body
Orbital cellulitis
Retinal detachment
Obstetric Presentations
Hyperemesis gravidarum
Painful vaginal bleeding in pregnancy
Placenta previa
Placental abruption
Preeclampsia:eclampsia
Preterm labor
Threatened:inevitable:incomplete abortion
Systemic and Miscellaneous Presentations
Anaphylaxis
Angioedema
Cannabis-induced hyperemesis
Anthrax (Gastrointestinal)
POCUS
Procedures
Calculators
Resuscitation
ECG Guide
Back
Clinical Assessment Checklist
Browse categories and answer follow-up questions to refine your symptom profile.
Approach to the Critical Patient
Immediate priorities
Airway and breathing threats
▶
Oropharyngeal variant airway compromise
▶
Massive cervical edema and neck swelling
Pharyngeal pseudomembrane obstructing airway
Mediastinal involvement
▶
Mediastinal widening can occur with GI anthrax
Pleural effusion causing respiratory compromise
If progressive pharyngeal edema, early definitive airway control
▶
Anticipate difficult airway
Anesthesia and surgical airway backup at bedside
Circulation and toxemia threats
▶
Hemorrhagic shock physiology
▶
Massive GI bleeding source
SBP < 90 mmHg
Distributive shock from toxemia
▶
MAP < 65 mmHg
Lactate >= 2 mmol/l
If shock, aggressive crystalloid resuscitation and early vasopressors
▶
Norepinephrine first line
Blood products for hemorrhage
Time-critical antitoxin and antibiotics
▶
Empiric therapy before confirmation
▶
Do not delay for laboratory confirmation
First antibiotic dose within 1 hour of suspicion
Antitoxin coordination
▶
Raxibacumab or obiltoxaximab via CDC
Anthrax immune globulin alternative
If systemic disease suspected, triple IV regimen plus antitoxin
▶
CDC 2023 guideline recommendation
Add CNS-penetrating agent if meningitis not excluded
Monitoring and targets
Monitoring bundle
▶
Continuous cardiorespiratory monitoring
▶
SpO2 target >= 94%
Cardiac monitor for sepsis arrhythmia
Hemodynamic targets
▶
MAP >= 65 mmHg
Urine output >= 0.5 ml/kg/hr
Serial reassessment cadence
▶
Abdominal exam trend for perforation
Mental status trend for meningitis
Escalation triggers
▶
Refractory shock after fluids
▶
Vasopressor requirement
ICU level care
New neurologic findings
▶
Suspect hemorrhagic meningitis
Urgent neuroimaging and lumbar puncture planning
Acute abdomen evolution
▶
Surgical consultation
Operative source control consideration
Public health activation
Mandatory notifications
▶
Immediate reporting
▶
Local and state health department
CDC Emergency Operations Center
Infection control
▶
Standard precautions adequate for naturally acquired disease
Person-to-person GI transmission not described
Bioterrorism consideration
▶
Cluster of cases triggers law enforcement notification
Laboratory Response Network engagement
History
Presentation pattern
Lower GI syndrome
▶
Initial prodrome
▶
Nausea and vomiting
Malaise and anorexia
Progressive phase
▶
Severe abdominal pain
Bloody diarrhea
Late phase
▶
Abdominal distention from ascites
Hematemesis or coffee-ground emesis
Oropharyngeal variant
▶
Local symptoms
▶
Sore throat and dysphagia
Neck swelling
Constitutional symptoms
▶
Fever
Regional lymphadenopathy
Timing and exposure
Incubation and tempo
▶
Incubation period 1-7 days
▶
Median onset 3 days after ingestion
Rapid systemic progression over days
Two-phase course
▶
Early GI symptoms
Acute abdomen presentation
Exposure history
▶
Dietary exposure
▶
Undercooked or raw herbivore meat
Sheep, goat, or cattle source
Geographic exposure
▶
Travel to sub-Saharan Africa or central Asia
Southern and eastern Europe endemic areas
Occupational and intentional exposure
▶
Agricultural or veterinary work
Suspected bioterrorism release
Risk factors and clues
Host risk factors
▶
Immunocompromised state
▶
Chronic corticosteroid use
Transplant or chemotherapy
Advanced age
▶
Delayed recognition
Higher mortality
Collateral clues
▶
Common-source exposure
▶
Household members with similar illness
Shared meal companions
Source characterization
▶
Meat origin and preparation
Traditional food practices
Important negatives
Distinguishing negatives
▶
No concurrent respiratory symptoms
▶
Helps distinguish inhalational anthrax
Reassess if dyspnea develops
No recent antibiotic use
▶
May alter culture yield
May blunt presentation
Physical Exam
Vitals and general
Stability snapshot
▶
Temperature
▶
Fever common
Hypothermia as severe sepsis marker
Hemodynamics
▶
Tachycardia
SBP < 90 mmHg as shock marker
General appearance
▶
Toxic appearance
Altered mental status
Abdominal exam
Abdominal findings
▶
Tenderness pattern
▶
Diffuse tenderness
Rebound and guarding with peritonitis
Distention and ascites
▶
Shifting dullness
Fluid wave
Perforation signs
▶
Rigid abdomen
Absent bowel sounds
Oropharyngeal exam
Oropharyngeal variant findings
▶
Mucosal lesions
▶
Oral or esophageal ulcers
Overlying pseudomembrane
Neck findings
▶
Massive cervical lymphadenopathy
Soft tissue edema with airway risk
Systemic and neurologic exam
Complication screen
▶
Meningeal signs
▶
Neck stiffness
Altered consciousness
Perfusion and bleeding
▶
Delayed capillary refill
Mucosal or GI bleeding
PITFALLS
Diagnostic traps
▶
Misattribution to common gastroenteritis
▶
Massive ascites is an atypical clue
Epidemiologic exposure prompts suspicion
Delayed recognition
▶
Nonspecific early prodrome
Rapid deterioration once systemic
Differential Diagnosis
Life threats and cannot-miss
Surgical and ischemic emergencies
▶
Intestinal perforation
▶
Free air on imaging
Peritonitis
Mesenteric ischemia
▶
Pain out of proportion
Lactic acidosis
Toxic megacolon
▶
Colonic dilatation
Systemic toxicity
Severe infectious mimics
▶
Sepsis from other bacteria
▶
ICD-10 A41.9 association
Source identification
Anthrax meningitis
▶
Up to 77% of systemic cases
Hemorrhagic CSF
Common GI mimics
Infectious enteritis
▶
Acute gastroenteritis
▶
Viral or bacterial
Self-limited course
Bacterial dysentery
▶
Shigella or Campylobacter
Bloody diarrhea overlap
Inflammatory and ulcer disease
▶
Inflammatory bowel disease flare
▶
Chronic relapsing pattern
No exposure history
Peptic ulcer with bleeding
▶
Melena or hematemesis
NSAID or H pylori history
Distinguishing features
Anthrax-specific clues
▶
Massive hemorrhagic ascites
▶
Distinguishes from typical gastroenteritis
Hemorrhagic mesenteric lymphadenitis on imaging
Microbiologic clues
▶
Large gram-positive bacilli in blood or ascites
Rapid growth in culture
Coding reference
▶
ICD-10 A22.2 gastrointestinal anthrax
SNOMED CT gastrointestinal anthrax disorder
Laboratory Tests
Microbiologic studies
Blood cultures
▶
High diagnostic yield
▶
B. anthracis grows rapidly
Obtain before antibiotics when feasible
Gram stain
▶
Large gram-positive bacilli
Boxcar-shaped chains
Confirmatory testing
▶
PCR at reference laboratory
▶
State health department access
Laboratory Response Network
Immunohistochemistry
▶
Tissue specimen staining
Serology limited and late
Hematologic and metabolic
Complete blood count
▶
White cell line
▶
Leukocytosis with left shift
Leukopenia as severe sepsis marker
Red cells and platelets
▶
Anemia from GI bleeding
Thrombocytopenia in severe cases
Metabolic and organ panels
▶
Comprehensive metabolic panel
▶
Hemoconcentration from fluid loss
Renal function for antibiotic dosing
Liver function tests
▶
Elevated transaminases
Sepsis-associated cholestasis
Perfusion and coagulation
Lactate
▶
Hypoperfusion marker
▶
>= 2 mmol/l significant
Repeat within 2-4 hours if elevated
Trend interpretation
▶
Clearance with resuscitation
Rising lactate triggers escalation
Coagulation studies
▶
PT, PTT, INR
▶
Coagulopathy in severe disease
Bleeding risk assessment
Fibrinogen and D-dimer
▶
DIC screening
Product replacement guidance
Ascitic fluid analysis
Diagnostic paracentesis
▶
Cell count and differential
▶
Neutrophil predominance
Inflammatory exudate
Microbiology
▶
Gram stain for large gram-positive bacilli
Culture for B. anthracis
Chemistry
▶
Protein, glucose, LDH
Appearance clear to purulent
Diagnostic Tests
Scoring Systems
Sepsis stratification tools
▶
qSOFA
▶
RR >= 22 per minute
SBP <= 100 mmHg
Altered mental status
SOFA score
▶
Organ dysfunction quantification
ICU prognostication
SIRS criteria
▶
Temperature and heart rate thresholds
Low specificity adjunct
Limitations
▶
No anthrax-specific score
▶
Generic sepsis tools applied
Clinical trajectory supersedes single score
Evidence note
▶
CDC 2023 emphasizes early empiric treatment over scoring
Exposure history drives suspicion
MRI
MRI brain
▶
Meningitis evaluation
▶
Hemorrhagic meningoencephalitis pattern
Subarachnoid and parenchymal hemorrhage
Indications
▶
New neurologic deficit
Altered mental status with sepsis
Contraindications
▶
Hemodynamic instability
Non-compatible implants
MRI abdomen role
▶
Problem-solving use
▶
Characterize complex collections
Limited acute availability
Preference for CT acutely
▶
Faster acquisition
Better for unstable patients
CT
CT abdomen and pelvis with contrast
▶
Key findings
▶
Bowel wall thickening
Massive ascites
Mesenteric findings
▶
Hemorrhagic mesenteric lymphadenitis
Terminal ileum and cecum involvement
Complication assessment
▶
Free air from perforation
Abscess collection
Contrast considerations
▶
Renal function review
Allergy history
CT chest
▶
Mediastinal evaluation
▶
Mediastinal widening reported in GI anthrax
Pleural effusion
CT head when neurologic
▶
Hemorrhage screen before lumbar puncture
Mass effect assessment
Ultrasound
Abdominal ultrasound
▶
Ascites assessment
▶
Free fluid quantification
Paracentesis guidance
Bowel and node survey
▶
Bowel wall edema
Mesenteric lymphadenopathy
Point-of-care ultrasound
▶
Shock evaluation
▶
IVC for volume status limits
Cardiac function gross estimate
Procedural guidance
▶
Ultrasound-guided paracentesis
Vascular access for resuscitation
Disposition
Level of care
Admission indications
▶
All suspected GI anthrax
▶
Need for IV antibiotics
Close monitoring requirement
Systemic illness
▶
Hemodynamic instability
Evidence of toxemia
ICU indications
▶
Shock and organ failure
▶
Vasopressor requirement
Multi-organ dysfunction
Airway and neurologic threats
▶
Oropharyngeal airway compromise
Suspected meningitis
Consultation and transfer
Specialist consultation
▶
Infectious disease
▶
Mandatory for all cases
Antimicrobial and antitoxin guidance
Surgery
▶
Acute abdomen or perforation
Operative source control
Critical care
▶
Severe systemic disease
Ventilatory or vasopressor needs
Transfer considerations
▶
Capability matching
▶
Centers with ICU and ID expertise
Access to antitoxin
Public health coordination
▶
Health department involvement
Maintain reporting chain
Discharge and follow-up
Copy
Discharge criteria
▶
Clinical improvement
▶
Hemodynamic stability
Tolerating oral intake
Therapy transition
▶
Switch to oral antibiotics when stable
Completion of IV course
Follow-up plan
▶
Reassessment timing
▶
24-48 hours after discharge
Weekly during antibiotic course
Specialist follow-up
▶
Infectious disease within 1 week
Counsel on full course completion
Treatment
Initial stabilization
Resuscitation
▶
Fluid therapy
▶
Balanced crystalloid for shock
Reassess after each bolus
Vasopressor support
▶
Norepinephrine first line
Titrate to MAP >= 65 mmHg
Hemorrhage management
▶
Packed red cells for significant bleeding
Correct coagulopathy
Airway protection
▶
Oropharyngeal edema
▶
Early intubation for progressive swelling
Surgical airway backup
NPO and decompression
▶
NPO with acute abdomen
Nasogastric decompression as needed
Antimicrobial therapy
Systemic disease triple regimen
▶
Bactericidal fluoroquinolone
▶
Ciprofloxacin 400 mg IV every 8-12 hours
Levofloxacin 750 mg IV daily alternative
Protein synthesis inhibitor for antitoxin effect
▶
Clindamycin 900 mg IV every 8 hours
Linezolid 600 mg IV every 12 hours alternative
CNS-penetrating beta-lactam if meningitis not excluded
▶
Meropenem 2 g IV every 8 hours
Penicillin G high dose if susceptible
Alternatives and cautions
▶
Doxycycline option
▶
Doxycycline 200 mg IV load then 100 mg IV every 12 hours
Avoid as sole CNS agent in meningitis
Monotherapy cautions
▶
Avoid penicillin or ampicillin alone
Beta-lactamase production concern
Combination rationale
▶
Bactericidal plus toxin-suppressing agent
CDC 2023 guideline structure
Antitoxin and adjuncts
Antitoxin therapy
▶
Monoclonal antibodies
▶
Raxibacumab single IV dose
Obiltoxaximab single IV dose
Anthrax immune globulin
▶
Polyclonal alternative
Obtain through CDC stockpile
Timing
▶
Add for systemic disease as early as possible
Adjunct to antibiotics not a replacement
Adjunctive measures
▶
Corticosteroids
▶
Severe edema or meningitis
Dexamethasone for cerebral edema
Source control
▶
Drainage of large effusions
Surgery for perforation
Supportive sepsis care
▶
Glycemic control
Stress ulcer prophylaxis
Duration and de-escalation
Treatment duration
▶
Naturally acquired disease
▶
2-3 weeks of effective therapy
Extend until clinically resolved
Bioterrorism exposure
▶
60 days total course
Concern for delayed spore germination
De-escalation strategy
▶
Oral transition
▶
Switch to oral once clinically stable
Ciprofloxacin or doxycycline oral
Tailoring by susceptibility
▶
Narrow per culture results
Continue toxin-suppressing agent as indicated
Special Populations
Pregnancy
Pregnancy considerations
▶
Maternal severity
▶
Higher risk of severe disease
Aggressive treatment warranted
Antibiotic selection
▶
Ciprofloxacin preferred when indicated
Avoid prolonged doxycycline when alternatives exist
Antitoxin and supportive care
▶
Antitoxin given for systemic disease
Fetal monitoring when viable gestation
Geriatric
Older adult features
▶
Atypical presentation
▶
Blunted fever response
Delirium as early sign
Higher mortality
▶
Reduced physiologic reserve
Earlier ICU consideration
Medication adjustment
▶
Renal dosing of fluoroquinolones
QT prolongation monitoring
Pediatrics
Pediatric differences
▶
Weight-based antibiotics
▶
Ciprofloxacin 10-15 mg/kg IV every 8-12 hours
Clindamycin 10-13 mg/kg IV every 8 hours
Meningitis-dose beta-lactam
▶
Meropenem 40 mg/kg IV every 8 hours
Maximum 2 g per dose
Agent cautions
▶
Doxycycline short course acceptable when needed
Monitor for dehydration from GI losses
Background
Epidemiology
Frequency and burden
▶
Rarity
▶
Rare form of anthrax
Follows ingestion of contaminated meat
Mortality
▶
25-60% mortality if untreated
Reduced with early aggressive therapy
Geographic distribution
▶
Endemic regions
▶
Sub-Saharan Africa and central Asia
Southern and eastern Europe
Sporadic regions
▶
Southwestern United States wildlife cases
Linked to agricultural exposure
Pathophysiology
Organism and toxins
▶
Bacillus anthracis
▶
Spore-forming gram-positive bacillus
Spores germinate in macrophages
Toxin components
▶
Protective antigen mediates cell entry
Lethal factor and edema factor drive injury
Disease mechanism
▶
Mucosal invasion
▶
Ulceration of GI tract
Spread to mesenteric lymph nodes
Systemic toxemia
▶
Hemorrhage and edema
Septic shock and multi-organ failure
Anatomic forms
▶
Oropharyngeal variant
▶
Upper GI ulcers and neck edema
Regional lymphadenopathy
Lower GI variant
▶
Terminal ileum and cecum predominance
Massive ascites and bleeding
Therapeutic Considerations
Antimicrobial principles
▶
Combination rationale
▶
Bactericidal agent plus toxin-suppressing agent
CNS-penetrating agent until meningitis excluded
Toxin suppression
▶
Protein synthesis inhibitors reduce toxin output
Clindamycin strongly recommended adjunct
Antitoxin role
▶
Targeting protective antigen
▶
Neutralizes circulating toxin
Adjunct for systemic disease
Access pathway
▶
CDC stockpile coordination
Early administration preferred
Public health integration
▶
Reportable disease
▶
Immediate notification required
Outbreak source investigation
Prevention
▶
Avoid undercooked herbivore meat
Postexposure prophylaxis for exposed contacts
Patient Discharge Instructions
copy discharge instructions
Copy
Gastrointestinal anthrax home care
▶
Take all antibiotics exactly as prescribed until finished
Complete the full course even if feeling better
Finish 60 days of antibiotics if exposure was intentional
Keep all follow-up appointments
Warning signs to return to ER
▶
Worsening or spreading abdominal pain
Swelling or hardness of the belly
Vomiting blood or passing bloody stools
Fever that returns or will not go away
Severe headache, confusion, or stiff neck
Trouble breathing or swallowing
Lightheadedness, fainting, or very little urine
Prevention and reporting
▶
Avoid undercooked meat especially from herbivores
Tell household members to watch for similar symptoms
Understand this is a reportable disease
Follow public health guidance for contacts
References
Guidelines and key sources
Guideline sources
▶
CDC Guidelines for the Prevention and Treatment of Anthrax 2023
▶
Bower WA et al MMWR Recommendations and Reports
Treatment and postexposure prophylaxis framework
Anthrax as a Biological Weapon updated recommendations
▶
Inglesby TV et al JAMA 2002
Working group consensus management
Evidence summaries
▶
Clinical management of bioterrorism-related conditions
▶
Adalja AA et al NEJM 2015
Systemic antibiotic therapy principles
Anthrax infection comprehensive review
▶
Sweeney DA et al AJRCCM 2011
Toxin-mediated pathophysiology
Coding standards
▶
ICD-10 A22.2 gastrointestinal anthrax
SNOMED CT gastrointestinal anthrax disorder concept
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.
← Management Protocols
Home
Management Protocols
Anthrax (Gastrointestinal)